Michigan
Phase 2 colorectal cancer trials in Michigan
10 Phase 2 colorectal cancer studies are recruiting participants at sites in 20 cities across Michigan as of November 18, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Michigan city with a recruiting study
Detroit (4), Ann Arbor (3), Grand Rapids (3), Dearborn (2), Flint (2), Lansing (2), Troy (2), Bay City (1), Brighton (1), Canton (1), Chelsea (1), Clarkston (1), Farmington Hills (1), Lapeer (1), Livonia (1), Macomb (1), Petoskey (1), Port Huron (1), Royal Oak (1), Ypsilanti (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Recently updated studies in Michigan
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Recruiting in
- Grand Rapids
- Registry record
- NCT07659795 · updated
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Recruiting in
- Grand Rapids
- Registry record
- NCT04557449 · updated
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Oncolytics Biotech
- Recruiting in
- Detroit
- Registry record
- NCT07446322 · updated
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Recruiting in
- Ann Arbor · Brighton · Canton · and 10 more U.S. locations
- Registry record
- NCT05673148 · updated
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Recruiting in
- Ann Arbor
- Registry record
- NCT06820463 · updated
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Recruiting in
- Ann Arbor
- Registry record
- NCT07023289 · updated
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Phase 2
- Ages 18 to 130
- All sexes
- Sponsor
- AstraZeneca
- Recruiting in
- Grand Rapids
- Registry record
- NCT05489211 · updated
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Endevica Bio
- Recruiting in
- Detroit
- Registry record
- NCT06937177 · updated
Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer
- Phase 2
- Ages 22 and older
- All sexes
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Recruiting in
- Bay City · Clarkston · Detroit · and 6 more U.S. locations
- Registry record
- NCT07130903 · updated
A Study of IBI363 in Subjects with Advanced Solid Malignancies
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Recruiting in
- Dearborn · Troy
- Registry record
- NCT06281678 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Michigan on ClinicalTrials.gov.
Ask about studies in Michigan
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 2, as each study is coded in the registry.
Colorectal Phase 2 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections